NCT03589326 2025-11-26A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic LeukemiaTakedaPhase 3 Active not recruiting245 enrolled 15 charts 2 FDA
NCT04233346 2025-04-04The Study for CML Who Failed Prior TKIs or With T315I Mutation or Ph+ ALL Who Failed Prior TKIs or With T315I MutationOtsuka Beijing Research InstitutePhase 2 Active not recruiting93 enrolled